Scientists launch deep dive into rare eye disease
NCT ID NCT05153057
First seen Mar 14, 2026 · Last updated Jun 22, 2026 · Updated 15 times
Summary
This study follows 600 people with birdshot chorioretinopathy, a rare inflammatory eye disease, to track how the condition changes over time. Researchers will use eye exams, imaging, and genetic tests to identify patterns and possible risk factors. The goal is to better understand the disease, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIRDSHOT CHORIORETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ophtalmopôle, Hôpital Cochin
RECRUITINGParis, Île-de-France Region, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could reveal genetic and clinical markers that help doctors better understand and manage birdshot chorioretinopathy.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence patient care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.